Cita APA (7a ed.)

Cabibbo, G., Reig, M., Celsa, C., Torres, F., Battaglia, S., Enea, M., . . . Cammà, C. (2021). First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future Trials. Karger Publishers.

Cita Chicago Style (17a ed.)

Cabibbo, Giuseppe, et al. First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future Trials. Karger Publishers, 2021.

Cita MLA (8a ed.)

Cabibbo, Giuseppe, et al. First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future Trials. Karger Publishers, 2021.